SUMMARY Using the leucocyte migration inhibition (LIF) test we looked for evidence of cellmediated hypersensitivity against myoglobin in 8 patients with polymyositis (PM) or dermatomyositis (DM). The migration index for PM-DM patients was 47-5 ± 17%, while in the controls the index was 86 ± 12% (p<OOO1). The presence of serum antibodies against myoglobin was also investigated by passive haemagglutination (PH) and counterimmunoelectrophoresis (CIE). By PH the reciprocal titre of antimyoglobin antibodies was 150 + 28 in PM-DM compared with 16-2 ± 15 9 and 8-7 ± 7 7 in control patients with diseases (p<OO1) and negative in normal persons.
Polymyositis (PM) is an inflammatory muscle disease that affects mainly proximal muscular groups; when the skin is affected it is called dermatomyositis (DM). The aetiology is unknown and the pathogenesis obscure; however, some immunological features have been described. These include direct mononuclear cytotoxicity to muscle fibres' 2 and lymphotoxinmediated cytotoxicity to fetal muscle when PM-DM mononuclear cells have been previously cultured with autologous muscle extract. 3 Passive haemagglutination (PH). SRBC were coated with human myoglobin by the technique described by Nishikai and Homma.'5 Myoglobincoated tanned SRBC (My-SRBC) were resuspended at 5 % in HBSS. The PH assays were done in Microtiter U-plate mictowells (Cooke Engineering, Alexandria. VA) containing 0-2 ml of 0 5% heatinactivated rabbit serum in HBSS, 0-2 ml of either patient or control serum in dilutions from 1:10 to 1:160, and 0-2 ml of My-SRBC suspension. The U-plates were first incubated for 60 min at 37°C and then overnight. After (Fig. 4) . In order to define the antimyoglobin specificity found by PH, absorption studies were done as follows: sera were incubated for 30 min at 37°C with 1% myoglobin solution in 0 01 M PBS. All sera tested in this way became negative for antimyoglobin activity by PH. A further attempt to define this specificity was by indirect immunofluorescence with mouse muscle as substrate. By this method all sera showed 2 staining patterns: both sarcolemmal and sarcoplasmatic.
When sera were previously absorbed with My-SRBC, the sarcoplasmatic staining disappeared and sarcolemmal remained positive (data not shown).
Counterimmunoelectrophoresis was positive in only 3 Further studies are required to define the significance of these findings.
We have demonstrated cell-mediated hypersensitivity to myoglobin by the LIF test in patients with PM-DM and confirmed the presence of antimyoglobin antibodies by PH. No previous study has reported cell-mediated immunity to a specific muscle antigen in PM-DM.
In PM-DM the cellular infiltrates in the inflamed muscles are mainly mononuclear, suggesting that a cell-mediated immune mechanism produces the tissue injury. Our findings are in accordance with this hypothesis. Several studies'`4 have found evidence of cell-mediated immunity against muscle in PM-DM, and our findings suggest that myoglobin is acting as antigen in this respect. Recently Haas23 failed to find antimuscle cytotoxicity with PM-DM mononuclear cells using xenogeneic target cells of rat origin. In our study the myoglobin was of human origin, so that in PM-DM the aberrant cellular immune response may be directed against antigenic determinants of myoglobin not shared by these 2 species, which does not myoglobin in polymyositis. 
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